SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after announcing record-high vehicle deliveries for December and the fourth quarter, significantly surpassing previous figures and nearing one million cumulative vehicles. This strong performance, further supported by extended EV subsidies in China, is driving considerable community discussion and optimism about the company's path to profitability and its competitive standing in the electric vehicle market.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions Inc. is trending following news of a strategic manufacturing partnership set to scale production of its drug screening reader for anticipated U.S. market entry. The community is actively discussing the stock's massive volume and micro-float, fueling excitement for potential short-squeeze-like parabolic gains. However, a recent private placement with lower-priced warrants has sparked debate among traders, creating a highly volatile environment with divided opinions on its immediate future.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is currently trending amidst significant investor confusion and frustration surrounding a recent dividend event and persistent tracking discrepancies with its underlying asset, SMCI. The community is actively questioning the ETF's unusual behavior, with some alleging it's a "scam" or facing an imminent reverse split, while others view the current downturn as a potential buying opportunity despite concerns about leveraged product decay.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is currently a hot topic, with community discussion centering on the ongoing delay and mixed initial data for its inhaled cystic fibrosis therapy, ARCT-032, which showed some mucus plug reduction but not significant lung function improvements. Investors are closely monitoring an active trade secret lawsuit against AbbVie, generating widespread hope for a substantial settlement or potential acquisition. Many believe the company's advanced mRNA platform and solid cash runway make the stock deeply undervalued amidst significant short interest.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP Crypto is trending after a recent price surge ignited a polarized community discussion. Supporters emphasize its real-world utility through Flexa's merchant network and anticipate significant growth with pending regulatory clarity and strategic partnerships. However, many investors express deep frustration, warning of sustained manipulation and a history of pump-and-dump cycles despite its technological foundations.

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

SpaceX is trending due to widespread anticipation of a potential IPO in 2026, which is igniting significant speculative interest across the broader aerospace sector. Community discussions are heavily focused on identifying "SpaceX IPO plays," with companies like Momentus ($MNTS) gaining traction for its partnership on Falcon 9 missions and a notably low share count, sparking comparisons to past explosive meme stock surges.

Grayscale Investments LLC - Grayscale Bitcoin Trust

Grayscale Bitcoin Trust

Grayscale Bitcoin Trust (GBTC) is trending amidst a fervent debate over Bitcoin's near-term price direction, with discussions highlighting recent ETF outflows and broader market dynamics. The community remains sharply divided, as many anticipate a "parabolic" rally for Bitcoin as a hedge against inflation, while others warn of an impending "crypto winter" and significant price corrections based on historical cycles and perceived lack of intrinsic value.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending amid intense community discussion following recent developments, including a partial summary judgment in its ongoing litigation and strategic changes to its executive team, which are fueling heightened speculation around a potential acquisition. Investors are closely monitoring progress for its rare disease therapy, MIPLYFFA, toward European market access and a patent term extension, while broadly criticizing management for perceived undervaluation and executive compensation. Despite these concerns, many maintain a bullish outlook, citing the company's significant cash reserves and pipeline assets as indicators of untapped value.

iShares Ethereum Trust (The) - Undivided Beneficial Interest

iShares Ethereum Trust ETF

iShares Ethereum Trust ETF ($ETHA) is trending amidst strong speculation surrounding spot Ethereum ETF approvals, particularly those offering staking, which is expected to drive institutional demand. The recent "Fusaka Upgrade" is also a key talking point, with its impact on Ethereum's burn rate fueling bullish outlooks and active options trading. While many investors are actively 'buying the dip' and positioning for a potential decoupling from Bitcoin, others maintain caution regarding crypto market volatility.

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is generating significant buzz after the FDA accepted its Biologics License Application for Veligrotug, granting Priority Review for Thyroid Eye Disease and setting a PDUFA target. The community is widely discussing Veligrotug's potential as a best-in-class treatment, citing its strong efficacy across both active and chronic TED compared to current therapies, which fuels analyst upgrades and M&A speculation for the company's innovative pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is First Trust NASDAQ-100-Technology Sector ETF (QTEC) a Strong ETF Right Now?

Worried About Oracle's Downfall? Hedge With These 5 Top-Ranked Tech ETFs

Oracle's selloff, tied to AI spending and debt fears, has rattled investors. Diversifying with top tech ETFs like XLK could help mitigate single-stock risk.

Should You Invest in the First Trust NASDAQ-100-Technology Sector ETF (QTEC)?

MongoDB (MDB) shares tumbled as much as 19% in pre-market trade on Thursday after issuing underwhelming guidance for fiscal 2026, triggering a downgrade from Wells Fargo and a wave of price target cuts across Wall Street.The database software company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/mongodb-plummets-aftermarket-as-guidance-misses-estimates/cheFYBNR68">reported</a> fourth-quarter (Q4) earnings per share (EPS) of $1.28, nearly doubling analysts’ expectations of $0.66.&nbsp;Revenue came in at $548.4 million, exceeding estimates of $519.84 million.Despite the strong results, Wall Street seems rattled by MongoDB’s outlook.&nbsp;The company projected fiscal 2026 revenue between $2.24 billion and $2.28 billion, falling short of the consensus estimate of $2.32 billion.&nbsp;Earnings guidance&nbsp;is forecast between&nbsp;$2.44 and $2.62, well below Wall Street’s estimate of $3.39.Wells Fargo downgraded the stock to ‘Equal Weight’ from ‘Overweight’ and slashed its price target by more than $100 to $225 from $365.The brokerage noted that MongoDB’s guidance and slowing multi-year deals suggest a challenging fiscal 2026.&nbsp;Wells Fargo views the upcoming year as a “transition period” for the company, warning that revenue growth will “significantly decelerate” and limit the stock’s upside.It added that MongoDB is still in the early stages of monetization, with Atlas starting to see further stabilization in its note to investors.&nbsp;Atlas revenue contributed to 68% of MongoDB's topline and climbed 32.6% year-over-year, outpacing overall company growth.Other major firms, including Barclays, Bank of America, Morgan Stanley, and Piper Sandler, maintained their ‘Buy’-equivalent ratings but reduced their price targets,&nbsp;citing the weak guidance, according to TheFly.<figure class="image"><img style="aspect-ratio:1296/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_03_06_073150_b10033171b.png" alt="Screenshot 2025-03-06 073150.png" width="1296" height="314"><figcaption>MongoDB retail sentiment and message volume on March 6 as of 7:30 a.m. ET | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/MDB">MongoDB’s stock</a> surged to ‘extremely bullish’ from ‘neutral’ a day ago, despite Wall Street’s pessimism.Retail chatter jumped to&nbsp;year highs,&nbsp;rising to ‘extremely high’ levels.Some users questioned why MongoDB consistently issues conservative guidance even though its earnings often align with estimates.<stembedurl>https://stocktwits.com/TheVoic/message/606971120</stembedurl>One user speculated that the stock may struggle to recover if the company continues to report negative profit margins and weak guidance each quarter.<stembedurl>https://stocktwits.com/Ranga14r/message/606969034</stembedurl>MongoDB shares have lost nearly 40% over the past year but remain up 12% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/traders-buy-strategy-stock-ahead-michael-saylor-at-trump-white-house-crypto-summit/cheF6mgR6U">Retail Traders Bet Big On Strategy’s Stock Ahead Of Michael Saylor’s Appearance At Trump’s White House Crypto Summit</a> &nbsp;

Mongodb Headquarters (Photo via Smith Collection/Gado/Getty Images).

MongoDB Stock Sinks Pre-Market As Weak Guidance Spawns Downgrade, Price Target Cuts – But Retail Isn’t Worried

Wells Fargo downgraded the stock to ‘Equal Weight’ from ‘Overweight’ and slashed its price target by more than $100 to $225 from $365.

Equity

Arm Holdings stock&nbsp;declined over 7%, while shares of Qualcomm rose over 2% after the latter won the legal dispute between the two companies.This marks a 4-month low for Arm, which was last seen trading at these levels in September.Over the weekend, a U.S. federal court sided with Qualcomm after a week-long trial, ruling that its licensing agreement with Arm remained intact despite claims of a breach.&nbsp;The dispute arose after Qualcomm acquired Nuvia, a startup that utilizes Arm's architecture in chip design.&nbsp;Arm alleged that Qualcomm owed higher royalties because Nuvia’s products fell under Qualcomm's umbrella, thus broadening its reliance on Arm’s patents.<figure class="image"><img style="aspect-ratio:1302/289;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_23_101118_e1d8a7efde.png" alt="Screenshot 2024-12-23 101118.png" width="1302" height="289"><figcaption>Arm Sentiment and Message Volume on Dec 23 as of 10:05 a.m. ET | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment around Arm remained ‘neutral,’ with chatter increasing to ‘normal’ from ‘low’ levels as users debated whether Qualcomm's partial win had impacted the status quo.&nbsp;<stembedurl>https://stocktwits.com/Vikingmilkman/message/597590709</stembedurl><stembedurl>https://stocktwits.com/jjg111/message/597587654</stembedurl><stembedurl>https://stocktwits.com/Bee4ev/message/597576980</stembedurl>The jury’s decision, however, wasn’t a complete win for Qualcomm. While the court determined no violation of the licensing terms, the jury couldn’t unanimously agree on whether Nuvia had breached its contract with Arm.&nbsp;This leaves room for further legal battles as Arm evaluates its options&nbsp;(suggest attributing this line to some source. Slightly sensitive). But at least for now, Qualcomm is off the hook, lifting retail sentiment.&nbsp;<figure class="image"><img style="aspect-ratio:1290/297;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_23_100946_f1fcb2bf39.png" alt="Screenshot 2024-12-23 100946.png" width="1290" height="297"><figcaption>Qualcomm Sentiment and Message Volume on Dec 23 as of 10:05 a.m. ET | Source: Stocktwits</figcaption></figure>While chatter around Qualcomm increased to ‘normal’ from ‘low’ a day ago, sentiment improved to ‘bullish’ from the ‘neutral’ zone.&nbsp;“We are pleased with today’s decision. The jury has vindicated Qualcomm’s right to innovate and affirmed that all the Qualcomm products at issue in the case are protected by Qualcomm’s contract with ARM,” the company said in a statement.“We will continue to develop performance-leading, world class products that benefit consumers worldwide, with our incredible Oryon ARM-compliant custom CPUs,” it added.<a href="https://stocktwits.com/symbol/ARM">Arm Holdings</a> is yet to comment on the verdict.&nbsp;Despite Arm’s dip&nbsp;on Monday, the stock is up over 81% year-to-date, far higher than Qualcomm’s 11% gains&nbsp;in the period.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/arm-stock-slips-as-legal-battle-with-qualcomm-kicks-off-in-delaware/cJaltZYR1L">Arm Stock Slips As Court Room Battle With Qualcomm Kicks Off In Delaware: Retail Divided</a>

POLAND - 2023/09/19: In this photo illustration, the Arm Holdings logo seen displayed on a smartphone with stock market percentages in the background. (Photo Illustration by Omar Marques/SOPA Images/LightRocket via Getty Images)

Arm Stock Slides To 4-Month Low As Qualcomm Jumps On Victory In Licensing Dispute: Retail Remains Unswayed

The jury’s decision, however, wasn’t a complete win for Qualcomm leaving room for further legal battles as Arm evaluates its options.

Super Micro Computer, Inc. ($SMCI) stock pulled back sharply on Tuesday, a day after traders bid up the stock on the relief that the artificial intelligence server maker dodged the delisting bullet, at least for now.At last check, the stock was down 8.26% at $40.51, having traded in the $39.78&nbsp;to&nbsp;$43.35 range.Late Friday,&nbsp;Super Micro&nbsp;confirmed that the Nasdaq granted time until Feb. 25, 2025, to file its&nbsp;annual report on Form 10-K for the fiscal year ending June 30, 2024, and its quarterly report on Form 10-Q for the period ending Sept. 30, 2024.&nbsp;Reacting to the news,&nbsp;the company’s shares rose as much as 9.3% intraday on Monday before giving back most of the gains. At the close, the stock was up 0.52% at $44.16.&nbsp;Tuesday’s weakness comes amid lingering worries about whether Super Micro can meet the late-February deadline and the declines in some AI-levered stocks.Retail, however, is optimistic. A poll run by Stocktwits showed that 84% of the respondents expected Super Micro to file its quarterly report by the Nasdaq-granted deadline.&nbsp;<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/smci_poll_9ad2e4c39f.png" alt="smci_poll.png">Among AI news flow, Taiwan Semiconductor Manufacturing Co. Ltd. (<a class="mention" data-mention="$TSM" data-symbol-id="TSM" href="https://stocktwits.com/symbol/TSM" target="_blank">$TSM</a>), the world’s biggest chip supplier, reported a 12% month-over-month drop in November revenue.&nbsp; On a year-over-year basis, revenue was up a solid 34% but the stock slipped over 2%.Shares of enterprise AI software applications company c3.ai, Inc. ($AI) were down about 0.50% after it widened its full-year loss guidance. The 10-Q report filed with the SEC showed CEO Thomas Siebel adopted a plan to sell 12.78 million Class A shares of the company, with the plan set to expire by Dec. 17, 2026.Retail sentiment toward Super&nbsp;Micro’s stock improved from ‘bearish’ a day ago to ‘bullish’ (60/100), with message volume remaining ‘normal.’<figure class="image"><img style="aspect-ratio:642/133;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/smci_sentiment_f6c64ef7ef.png" alt="smci-sentiment.png" width="642" height="133"><figcaption>SMCI sentiment and message volume December 10, 2024, as of 11:33 am ET | Source:&nbsp;Stocktwits</figcaption></figure>A Stocktwits user saw the plunge as normal for volatile stocks, especially after big run-ups.<stembedurl>https://stocktwits.com/Kevothe1/message/595862316</stembedurl>Another said he would use the opportunity to “re-load.”&nbsp;<stembedurl>https://stocktwits.com/postrade/message/595862248</stembedurl>Notwithstanding the stock volatility,&nbsp;Super Micro’s shares are&nbsp;up over 55% for the year, although they are trading&nbsp;well off the March 8 intraday high of $122.90.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Super Micro Computer, Inc. (Supermicro) logo appears on the screen of a smartphone in Reno, United States, on December 7, 2024.

Super Micro’s Volatile Run Continues As Stock Teeters Around $40 Following 9% Drop: Retail Turns Constructive

Tuesday’s weakness comes amid lingering worries about whether Super Micro can meet the late-February deadline and the declines in some AI-levered stocks.

Shares of MongoDB fell as much as 8% in pre-market trading despite reporting strong third-quarter results and raising its full-year outlook on news that the company’s COO and CFO, Michael Gordon, would be stepping down.&nbsp;According to an ongoing poll on Stocktwits, most users find the development “very concerning.”<figure class="image"><img style="aspect-ratio:1262/709;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/mongodb_poll_e3c26d3178.jpg" alt="mongodb poll.jpg" width="1262" height="709"><figcaption>Stocktwits Poll on MongoDB's CFO, COO Exit on Dec 10 as of 7:00 a.m. ET | Source: Stocktwits</figcaption></figure>The company announced it has initiated a search for a new CFO, considering both internal and external candidates.&nbsp;Serge Tanjga, MongoDB's president of finance, will serve as interim CFO starting Feb. 1 if a permanent replacement is not found by then.The data development, storage, and management platform reported adjusted earnings of $1.16 per share, surpassing analysts' estimates of $0.68.&nbsp;Revenue came in at $529.4 million, marking a 22% year-over-year (YoY) growth and exceeding forecasts of $497.24 million.“We continue to see success winning new business due to the superiority of MongoDB’s developer data platform in addressing a wide variety of mission-critical use cases,” Chief Executive Dev Ittycheria said in a statement.For the full fiscal year, MongoDB raised its revenue guidance to a range of $1.973 billion to $1.977 billion, up from its previous outlook of $1.92 billion to $1.93 billion.&nbsp;Full-year adjusted earnings per share are now expected to range between $3.01 and $3.03, compared to the earlier projection of $2.33 to $2.47.However, the company noted potential headwinds in Q4. Non-Atlas revenue is projected to decline sequentially due to significant multi-year deals closed in Q3 that won't repeat.&nbsp;Meanwhile, Atlas consumption is expected to slow YoY in Q4, reflecting a seasonal drop in application usage during the holidays.Moreover, MongoDB is redirecting its go-to-market resources from mid-market customers to enterprise accounts. This strategic shift is expected to reduce mid-market customer additions and slow overall direct sales growth.<figure class="image"><img style="aspect-ratio:1293/301;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_10_064754_dc1c71389c.png" alt="Screenshot 2024-12-10 064754.png" width="1293" height="301"><figcaption>MongoDB Sentiment and Message Volume on Dec 9 as of 7:00 a.m. ET | Source: Stocktwits</figcaption></figure>Retail sentiment around the stock saw an uptick to ‘extremely bullish’ (93/100) from ‘bullish a day ago, along with an increase in chatter to ‘extremely high,’ marking the highest activity on the ticker this year.&nbsp;<stembedurl>https://stocktwits.com/YouAndMe_ToTheMoon/message/595816543</stembedurl><stembedurl>https://stocktwits.com/marti837/message/595816616</stembedurl>While <a href="https://stocktwits.com/symbol/MDB">MongoDB shares</a> gained as much as 6% after hours on Monday, some users speculated that Oracle's disappointing earnings, reported earlier Tuesday, might be weighing on MongoDB's stock performance. Oracle's dominance in the database market could lead to broader sector concerns.<stembedurl>https://stocktwits.com/Sbul26/message/595816930</stembedurl>Overall, the stock is down nearly 9% so far this year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/amazon-stock-price-hits-all-time-high-on-bitcoin-proposal/cJab2C3RiW">Amazon Stock Hits Fresh Record High On Shareholders Call To Add Bitcoin To $88 Billion Treasury: Retail Onboard</a>

MongoDB Stock Slips Pre-Market Despite Q3 Earnings Beat On CFO’s Exit: Retail Holds On

Leadership shifts and slowing Atlas growth spark mixed reactions to MongoDB's third-quarter performance.

Super Micro Computer, Inc. ($SMCI) shares took off in Friday’s after-hours trading after the artificial intelligence server maker announced that the Nasdaq has granted it an extension to be up-to-date with the filing of its financial reports.The San Jose, California-based company said it received a letter from Nasdaq granting its request for an exception to Nasdaq rule 5250(c)(1) through Feb. 25, 2025. The rule mandates that companies listed on the exchange should file all required periodic financial reports with the SEC on or before the filing deadline.&nbsp;Super Micro has delayed the filing its annual report on Form 10-K for the fiscal year ending June 30, 2024, and its quarterly report on Form 10-Q for the period ending Sept. 30, 2024. The predicament came amid the company's then-auditor Ernst &amp; Young stepping down after flagging concerns regarding accounting practices and internal controls.&nbsp;The AI server maker has since then appointed a new auditor. Also, an independent committee appointed by the board's audit commit to probe the allegations recently gave a chit to the company.Super Micro said its stock will remain on the exchange during the exception period and expects to file all the required reports by Feb. 25, 2025.After settling Friday’s regular session up 6.78% at $43.93, Super Micro stock climbed 8.70% to $47.75 in the after-hours session.<figure class="image"><img style="aspect-ratio:637/137;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/smci_sentiment_ac9acf04b5.png" alt="smci-sentiment.png" width="637" height="137"><figcaption>SMCI sentiment and message volume December 8, 2024, as of 10:20 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>Notwithstanding the stock rally, retail sentiment toward the stock was downbeat. On Stocktwits, the sentiment meter read 45/100, suggesting a ‘neutral’ mood, while message volume remained ‘low.’A Stocktwits user deemed the extension allowed as a “very short period,” and called to short the stock.<stembedurl>https://stocktwits.com/Sevenele/message/595623014</stembedurl>Another predicted a big pre-market jump on Monday and then a rapid pullback toward the low-$40s from sell-the-news dumplings.<stembedurl>https://stocktwits.com/wtwttt2/message/595520625</stembedurl>&nbsp;But those bullish retailers have begun setting sights on the stock breaching $50.<stembedurl>https://stocktwits.com/UnicornFarts/message/595637770</stembedurl><a href="https://stocktwits.com/symbol/SMCI">Super Micro shares</a>, which had a parabolic run through March this year, have come off the intraday peak of $122.90 (March 8). The stock is currently nestled between its 50-day simple moving (SMA) of $37.13 and 100-day SMA of $46.25. If it breaks above the psychological resistance of $50, it could look to backfill a gap from late August and go past the $54 mark.<figure class="image"><img style="aspect-ratio:1534/849;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/SMCI_T_Vchart_7877003806.png" alt="SMCI-TVchart.png" width="1534" height="849"><figcaption>Chart Courtesy of TradingView</figcaption></figure>Last week, Super Micro CEO Charles Liang announced that the company would support Elon Musk-founded xAI’s massive 10-fold expansion of the Colossus supercomputer in Memphis with over 1 million GPUs. The company would help by establishing local operations/production, validation, service and support, he added.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Super Micro Stock Poised To Test $50 Resistance As Nasdaq Grants Extension: Skeptic Retail Stays On Sidelines

Super Micro said its stock will remain on the exchange during the exception period allowed by the Nasdaq and expects to file all the required reports by Feb. 25, 2025.

Super Micro Computer, Inc. ($SMCI) shares are on track to record their second consecutive session of gains, and the retail is slowly returning to the bullish camp.In premarket trading, as of 9:06 a.m. ET, Super Micro stock climbed 3.91% to $43.65. If the premarket gains hold up, the stock is on track to open at its highest level since late October.On Monday, Super Micro stock was up 28.68% at $42 by the close of trading, having touched an intra-day high of $44.15. Monday's rally came amid above-average volume, lending credence to the upward move.The positive catalyst was a statement that the independent special committee instituted by the board found no evidence of misconduct on the part of the management or the board. The committee gave a clean chit to the board's audit committee, stating that it acted independently.It added that&nbsp;Super Micro’s former auditor Ernst &amp; Young’s resignation and the conclusions the firm stated in the resignation letter were not supported by the facts examined in the review.Super Micro also said, as it said in the compliance plan filed with the Nasdaq on Nov. 18, it will be able to complete its annual report on Form 10-K for the year June 30, 2024, and the quarterly report on 10-Q for the September quarter. within the discretionary period available to the Nasdaq staff to grant.&nbsp;The company does not expect any restatements related to those delayed reports.Commenting on the development, JPMorgan said that despite the findings, the committee made some recommendations, including the appointment of a new CFO to succeed the incumbent David Weigand and setting up new roles of chief accounting and compliance officer and general counsel, the Fly <a target="_blank" rel="noopener noreferrer nofollow" href="https://thefly.com/news.php?symbol=SMCI">reported.</a>The firm said it remains sidelined on the stock until visibility on compliance improves.&nbsp;The next key developments to watch are whether the new auditor BDO accepts the committee’s findings or decides to undertake its review and whether the Nasdaq supported Super Micro’s request for an extension of time to regain compliance.<figure class="image"><img style="aspect-ratio:632/128;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/smci_sentiment_c7b9c5f25e.png" alt="smci-sentiment.png" width="632" height="128"><figcaption>SMCI sentiment and message volume December 3, 2024, premarket as of 9:06 am ET | Source:&nbsp;Stocktwits</figcaption></figure>Retail sentiment toward Super Micro stock has improved to ‘bullish’ (55/100) from a ‘neutral’ a day ago, with message volume also improving to ‘high’ levels.Technically, if the stock manages to fill the gap from late October, it could test a near-term resistance around the $50 level. On the downside, it has support around the 50-day moving average around $37.<figure class="image"><img style="aspect-ratio:1507/818;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/smci_chart_33cb3378aa.png" alt="smci-chart.png" width="1507" height="818"><figcaption>Chart Courtesy of TradingView</figcaption></figure>Notwithstanding this year's checkered stock performance, Super Micro is still up about 48%, although it is trading way off the $122.90 intraday high reached on March 8.For updates and corrections email newsroom[at]stocktwits[dot]com.

Super Micro’s stock is still up about 48% year-to-date.

Super Micro Stock Rallies In Premarket Amid Ongoing Momentum, Retail Jumps To Bullish Camp

Next key developments to watch are whether the new auditor BDO accepts the independent committee’s findings and whether Nasdaq agrees to Super Micro’s compliance plan, said JPMorgan.

QTEC
First Trust Exchange-Traded Fund III - First Trust NASDAQ-100 Technology Sector Index Fund

Feed

News

Sentiment

Fundamentals

Info

Latest QTEC News

QTECFirst Trust Exchange-Traded Fund III - First Trust NASDAQ-100 Technology Sector Index Fund